Op-Ed: Quick fix for any strain of COVID? Nasal spray “prevents COVID from infecting cells”


A White House official said the United States will distribute 500 million free Covid tests as Omicron cases increase. – © AFP

OK, maybe miracles happen, a little bit, at least. A team of researchers from the universities of Melbourne, Oxford and Monash were work on an existing drug, heparin, as a nasal spray for an all-purpose COVID blocker. The results so far are promising, and it should be tested in Victoria within the next six months.

Heparin is usually an anticoagulant. It was discovered in 1916 and has since had a long record of development. The drug has received a lot of attention in the news for some time. Heparin has been shown to have several notable antiviral properties, specifically binding to COVID peaks.

This treatment option is highly credible and supported by other research. It is also an interesting and very practical solution for all kinds of mass distribution.

This is very good news in some less obvious ways:

COVID is the virus poster for high transmissibility human-to-human respiratory viruses. The ability to stop infection at the point of contact may well be ‘game over’ for the pandemic.

The bottom line here is that this way of dealing with COVID is systemic. If the virus cannot infect, it cannot replicate itself. If it cannot replicate, it cannot propagate. If it cannot spread, the viral population will collapse and it is highly likely that there will be fewer or no new strains.

Heparin is suitable for the time; it is easy to manufacture, it is a known medicine, it can be stored at room temperature and only one spray if necessary is sufficient.

A week of new cases of Covid-19. – © AFP

Future options

Nasal sprays have performed best in the last decade or so. Fentanyl is administered by spray. Extrapolate this way of doing things for other intractable viral parasites, common childhood infections, and nasty tropical diseases, and it really is a great methodology.

This is where immunology meets all the criteria:

  • Simple.
  • Low risk due to method of administration.
  • Non intrusive.
  • Easy commercial and production logistics.
  • Administration is painless and non-threatening.
  • Precision metrics and quality control for dosages of just about anything.
  • Long term storage.

It is really “vaccination by other means”. Conventional vaccinations have an Achilles heel – they require relatively high maintenance and a higher cost, even at basic modern cost levels. They are finicky and have a relatively high turnover if not used within specific time frames. Don’t be too surprised to spend almost 5 seconds at your local GP to get a series of “updates” on your vaccinations going forward.

Just one last thing – A pneumonic plague has been the doomsday pandemic scenario. It was the one who was going to crush humanity. Fix that with a nasal spray, and that menace is gone. Very nice Christmas present, right?


Comments are closed.